Parkinson's Disease Reply

被引：0
作者：
Tanner, Caroline M. [1 ]
Ostrem, Jill L. [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2024年 / 391卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1559 / 1559
页数：1
相关论文
共 50 条
[41]   Body mass index in Parkinson's disease - Reply [J].
Cheshire, WP ;
Wszolek, ZK .
PARKINSONISM & RELATED DISORDERS, 2005, 11 (06) :409-409
[42]   Reply: ARSA gene variants and Parkinson's disease [J].
Lee, Seung-Jae ;
Lee, Jun Sung ;
Funayama, Manabu ;
Yoo, Han Soo ;
Lee, Phil Hyu ;
Hattori, Nobutaka .
BRAIN, 2020, 143
[43]   Reply: a new look at the pathogenesis of Parkinson's disease [J].
Przedborski, S ;
Vila, M ;
Jackson-Lewis, V ;
Dawson, TM .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (05) :165-165
[44]   Should risperidone be used in Parkinson's disease? Reply [J].
Workman, RH .
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 1998, 10 (04) :474-475
[45]   Reply to: "Parkinson's Disease, Premature Mortality, and Amygdala" [J].
Laansma, Max A. ;
Bright, Joanna K. ;
Jahanshad, Neda ;
Thompson, Paul M. ;
van Der Werf, Ysbrand D. .
MOVEMENT DISORDERS, 2022, 37 (05) :1111-1112
[46]   Reply to: "Rethinking Parkinson's Disease: A Syndromic Perspective" [J].
Outeiro, Tiago F. ;
Antonini, Angelo ;
Ferreira, Joaquim J. .
MOVEMENT DISORDERS, 2024, 39 (06) :1080-1081
[47]   Reply to: "Risk Disclosure in Prodromal Parkinson's Disease" [J].
Schaeffer, Eva ;
Toedt, Inken ;
Kohler, Susanne ;
Rogge, Annette ;
Berg, Daniela .
MOVEMENT DISORDERS, 2022, 37 (06) :1327-1327
[48]   Parkinson disease REPLY [J].
Fernandez, Hubert H. .
CLEVELAND CLINIC JOURNAL OF MEDICINE, 2012, 79 (04) :243-+
[49]   PARKINSON DISEASE Reply [J].
Hu, G. ;
Antikainen, R. ;
Jousilahti, P. ;
Kivipelto, M. ;
Tuomilehto, J. .
NEUROLOGY, 2009, 72 (09) :860-861
[50]   Ophthalmologic features of Parkinson's disease - Reply from the authors [J].
Biousse, V ;
Newman, NJ .
NEUROLOGY, 2004, 63 (05) :940-941
12345